Literature DB >> 19734397

The decision to intensify therapy in patients with type 2 diabetes: results from an experiment using a clinical case vignette.

Richard W Grant1, Karen E Lutfey, Eric Gerstenberger, Carol L Link, Lisa D Marceau, John B McKinlay.   

Abstract

PURPOSE: Lack of medication intensification is a widely recognized but poorly understood barrier to effective diabetes care. We used a video case vignette to assess whether patient or physician demographic variables influence the decision to intensify therapy.
METHODS: One hundred ninety-two US primary care physicians each viewed one case vignette of an actor portraying a patient who had type 2 diabetes and borderline indications for medication intensification. Case vignettes were clinically identical and differed only by patient age (35 or 65 years old); sex; race/ethnicity (white, Hispanic, or black); and socioeconomic status (occupation of lawyer or janitor). After viewing the vignette and indicating their management plans, physicians were also asked to discuss the challenges related to managing such a patient.
RESULTS: Just over half (53%) of physicians indicated that they would recommend a medication prescription for the vignette patient. Demographic characteristics (of the patient, physician, or practice) did not significantly influence this decision (P > .1 for all comparisons). Compared with physicians who did not recommend a diabetic-related prescription, physicians recommending therapy more often identified patient medication costs (74% vs 43% of physicians who would not increase therapy); medication adherence (63% vs 49%); and subsequent complications (34% vs 22%) as important clinical issues in managing diabetes. Physicians not intensifying therapy more often indicated that they needed more clinical information (16% vs 9%).
CONCLUSIONS: Using an experimental design we found that differences in the decision to intensify therapy were not significantly explained by patient, physician, or practice demographic variables. Physicians who intensified therapy were more likely to consider issues such as medication costs, patient adherence, and downstream complications.

Entities:  

Mesh:

Year:  2009        PMID: 19734397      PMCID: PMC2787088          DOI: 10.3122/jabfm.2009.05.080232

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  21 in total

1.  Primary care physicians who treat blacks and whites.

Authors:  Peter B Bach; Hoangmai H Pham; Deborah Schrag; Ramsey C Tate; J Lee Hargraves
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Nonmedical influences on medical decision making: an experimental technique using videotapes, factorial design, and survey sampling.

Authors:  H A Feldman; J B McKinlay; D A Potter; K M Freund; R B Burns; M A Moskowitz; L E Kasten
Journal:  Health Serv Res       Date:  1997-08       Impact factor: 3.402

4.  Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality.

Authors:  J W Peabody; J Luck; P Glassman; T R Dresselhaus; M Lee
Journal:  JAMA       Date:  2000-04-05       Impact factor: 56.272

5.  The unexpected influence of physician attributes on clinical decisions: results of an experiment.

Authors:  John B McKinlay; Ting Lin; Karen Freund; Mark Moskowitz
Journal:  J Health Soc Behav       Date:  2002-03

6.  The effect of race and sex on physicians' recommendations for cardiac catheterization.

Authors:  K A Schulman; J A Berlin; W Harless; J F Kerner; S Sistrunk; B J Gersh; R Dubé; C K Taleghani; J E Burke; S Williams; J M Eisenberg; J J Escarce
Journal:  N Engl J Med       Date:  1999-02-25       Impact factor: 91.245

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.

Authors:  Margaret C Fang; Ellen P McCarthy; Daniel E Singer
Journal:  Am J Med       Date:  2004-10-15       Impact factor: 4.965

9.  Hypertension management in patients with diabetes: the need for more aggressive therapy.

Authors:  Dan R Berlowitz; Arlene S Ash; Elaine C Hickey; Mark Glickman; Robert Friedman; Boris Kader
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

10.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  5 in total

1.  Psychosocial information use for clinical decisions in diabetes care.

Authors:  Charles Senteio; Julia Adler-Milstein; Caroline Richardson; Tiffany Veinot
Journal:  J Am Med Inform Assoc       Date:  2019-08-01       Impact factor: 4.497

2.  Linking electronic health record-extracted psychosocial data in real-time to risk of readmission for heart failure.

Authors:  Alice J Watson; Julia O'Rourke; Kamal Jethwani; Aurel Cami; Theodore A Stern; Joseph C Kvedar; Henry C Chueh; Adrian H Zai
Journal:  Psychosomatics       Date:  2011 Jul-Aug       Impact factor: 2.386

Review 3.  Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review.

Authors:  Bruno Rushforth; Carolyn McCrorie; Liz Glidewell; Eleanor Midgley; Robbie Foy
Journal:  Br J Gen Pract       Date:  2016-02       Impact factor: 5.386

4.  Supporting Practices to Adopt Registry-Based Care (SPARC): protocol for a randomized controlled trial.

Authors:  Rebecca S Etz; Rosalind E Keith; Anna M Maternick; Karen L Stein; Roy T Sabo; Melissa S Hayes; Purvi Sevak; John Holland; Jesse C Crosson
Journal:  Implement Sci       Date:  2015-04-09       Impact factor: 7.327

Review 5.  Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.

Authors:  Carla Castillo-Laborde; Macarena Hirmas-Adauy; Isabel Matute; Anita Jasmen; Oscar Urrejola; Xaviera Molina; Camila Awad; Catalina Frey-Moreno; Sofia Pumarino-Lira; Fernando Descalzi-Rojas; Tomás José Ruiz; Barbara Plass
Journal:  Public Health Rev       Date:  2022-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.